Ligand id: 8325

Name: aducanumab

Compound class Antibody
International Nonproprietary Names
INN number INN
9838 aducanumab
BART | BIIB-037 | BIIB037
Aducanumab is a fully human IgG1-kappa monoclonal antibody directed against the amyloid beta (Aβ) found in the amyloid plaques in the brain tissue of patients with Alzheimer's disease (AD).
Peptide sequences and structural information about this antibody are available from its IMGT/mAb-DB record. A patent search reveals Biogen Idec's patent submission WO2014089500 [2].
Database Links
Specialist databases
IMGT/mAb-DB 479
Other databases
GtoPdb PubChem SID 252166537
Search PubMed clinical trials aducanumab
Search PubMed titles aducanumab
Search PubMed titles/abstracts aducanumab
Wikipedia Aducanumab